Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, Bruno P. Imbimbo, Andrea Santamato, Madia Lozupone, Rosa Capozzo, Camilla Prete, Alberto Pilotto, Antonio Greco & Giancarlo Logroscino. (2016) Tau aggregation inhibitors: the future of Alzheimer’s pharmacotherapy?. Expert Opinion on Pharmacotherapy 17:4, pages 457-461.
Read now
Read now
A Scott Nielsen. (2015) Advances in the management of relapsing–remitting multiple sclerosis: role of oral dimethyl fumarate (BG-12). Degenerative Neurological and Neuromuscular Disease 5, pages 51-61.
Read now
Read now
Articles from other publishers (17)
Federico Manai, Lisa Zanoletti, Davide Arfini, Simone Giorgio De Micco, Arolda Gjyzeli, Sergio Comincini & Marialaura Amadio. (2023) Dimethyl Fumarate and Intestine: From Main Suspect to Potential Ally against Gut Disorders. International Journal of Molecular Sciences 24:12, pages 9912.
Crossref
Crossref
Panagiotis Theodosis-Nobelos & Eleni A. Rekka. (2022) Efforts Towards Repurposing of Antioxidant Drugs and Active Compounds for Multiple Sclerosis Control. Neurochemical Research 48:3, pages 725-744.
Crossref
Crossref
Federico Manai, Stefano Govoni & Marialaura Amadio. (2022) The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies. Cells 11:24, pages 4061.
Crossref
Crossref
Shilu Deepa Thomas, Niraj Kumar Jha, Bassem Sadek & Shreesh Ojha. (2022) Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise. Pharmaceuticals 15:5, pages 497.
Crossref
Crossref
Khadijeh Mousavi, Hossein Niknahad, Huifeng Li, Zhipeng Jia, Ram Kumar Manthari, Yangfei Zhao, Xiong Shi, Yuanyu Chen, Asrin Ahmadi, Negar Azarpira, Bahman Khalvati, Mohammad Mehdi Ommati & Reza Heidari. (2021) The activation of nuclear factor-E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling blunts cholestasis-induced liver and kidney injury. Toxicology Research 10:4, pages 911-927.
Crossref
Crossref
Mithun Singh Rajput, Nilesh Prakash Nirmal, Devashish Rathore & Rashmi Dahima. (2020) Dimethyl Fumarate Mitigates Tauopathy in Aβ-Induced Neuroblastoma SH-SY5Y Cells. Neurochemical Research 45:11, pages 2641-2652.
Crossref
Crossref
Valentina Pegoretti, Kathryn A. Swanson, John R. Bethea, Lesley Probert, Ulrich L. M. Eisel & Roman Fischer. (2020) Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development. Oxidative Medicine and Cellular Longevity 2020, pages 1-19.
Crossref
Crossref
Hugo Gonzalo, Lara Nogueras, Anna Gil-Sánchez, José Vicente Hervás, Petya Valcheva, Cristina González-Mingot, Meritxell Martin-Gari, Marc Canudes, Silvia Peralta, Maria José Solana, Reinald Pamplona, Manuel Portero-Otin, Jordi Boada, Jose Carlos Enrique Serrano & Luis Brieva. (2019) Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients. Frontiers in Neuroscience 13.
Crossref
Crossref
Gaojian Lian, JN Rashida Gnanaprakasam, Tingting Wang, Ruohan Wu, Xuyong Chen, Lingling Liu, Yuqing Shen, Mao Yang, Jun Yang, Ying Chen, Vasilis Vasiliou, Teresa A Cassel, Douglas R Green, Yusen Liu, Teresa WM Fan & Ruoning Wang. (2018) Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation. eLife 7.
Crossref
Crossref
Amanda Pedder. (2018) Treating Psoriasis: What Is New About Fumaric Acid Esters?. European Medical Journal, pages 25-33.
Crossref
Crossref
Jürgen Brück, Ralf Dringen, Adriana Amasuno, Ignasi Pau-Charles & Kamran Ghoreschi. (2018) A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis. Experimental Dermatology 27:6, pages 611-624.
Crossref
Crossref
Martha Garstkiewicz, Gerhard E. Strittmatter, Serena Grossi, Jennifer Sand, Gabriele Fenini, Sabine Werner, Lars E. French & Hans-Dietmar Beer. (2017) Opposing effects of Nrf2 and Nrf2-activating compounds on the NLRP3 inflammasome independent of Nrf2-mediated gene expression. European Journal of Immunology 47:5, pages 806-817.
Crossref
Crossref
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Bruno P Imbimbo, Madia Lozupone, Andrea Santamato, Rosanna Tortelli, Ilaria Galizia, Camilla Prete, Antonio Daniele, Alberto Pilotto, Antonio Greco & Giancarlo Logroscino. (2016) Tau-based therapeutics for Alzheimer’s disease: active and passive immunotherapy. Immunotherapy 8:9, pages 1119-1134.
Crossref
Crossref
Wen-Xian Zhang, Jian-Hong Zhao, Fu-Min Ping, Zhi-Jun Liu, Jun-Xia Gu & Xin-Qing Lu. (2016) Effect of dimethyl fumarate on rats with chronic pancreatitis. Asian Pacific Journal of Tropical Medicine 9:3, pages 261-264.
Crossref
Crossref
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Bruno P. Imbimbo, Madia Lozupone, Andrea Santamato, Chiara Zecca, Maria Rosaria Barulli, Antonello Bellomo, Alberto Pilotto, Antonio Daniele, Antonio Greco & Giancarlo Logroscino. (2016) Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease. BioMed Research International 2016, pages 1-15.
Crossref
Crossref
Bożena Adamczyk & Monika Adamczyk-Sowa. (2016) New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis. Oxidative Medicine and Cellular Longevity 2016, pages 1-18.
Crossref
Crossref
Hui Chen, Julian C. Assmann, Antje Krenz, Mahbubur Rahman, Myriam Grimm, Christian M. Karsten, Jörg Köhl, Stefan Offermanns, Nina Wettschureck & Markus Schwaninger. (2014) Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate’s protective effect in EAE. Journal of Clinical Investigation 124:5, pages 2188-2192.
Crossref
Crossref